InvestorsHub Logo
Followers 74
Posts 16346
Boards Moderated 3
Alias Born 04/24/2000

Re: Theo post# 1646

Thursday, 11/09/2017 6:32:14 PM

Thursday, November 09, 2017 6:32:14 PM

Post# of 2104
Private money adding to holdings: Courage Capital Management Has Raised Holding in Conatus Pharmaceuticals Ord Shs (CNAT) by $375,000

...and a good read on other private and public equity holders: DAFNA Capital Management LLC Buys Shares of 50,000 Conatus Pharmaceuticals Inc. (CNAT)

"A number of other institutional investors and hedge funds have also bought and sold shares of CNAT. Nationwide Fund Advisors acquired a new stake in Conatus Pharmaceuticals during the first quarter worth $413,000. Bank of New York Mellon Corp boosted its stake in shares of Conatus Pharmaceuticals by 2.1% in the 1st quarter. Bank of New York Mellon Corp now owns 80,310 shares of the biotechnology company’s stock valued at $464,000 after purchasing an additional 1,655 shares in the last quarter. Renaissance Technologies LLC boosted its stake in shares of Conatus Pharmaceuticals by 28.1% in the 1st quarter. Renaissance Technologies LLC now owns 235,290 shares of the biotechnology company’s stock valued at $1,358,000 after purchasing an additional 51,590 shares in the last quarter. Courage Capital Management LLC boosted its stake in shares of Conatus Pharmaceuticals by 25.0% in the 1st quarter. Courage Capital Management LLC now owns 125,000 shares of the biotechnology company’s stock valued at $721,000 after purchasing an additional 25,000 shares in the last quarter. Finally, Bank of Montreal Can acquired a new stake in shares of Conatus Pharmaceuticals in the 2nd quarter valued at $109,000. Hedge funds and other institutional investors own 33.13% of the company’s stock."

Theo ;-)